FINWIRES · TerminalLIVE
FINWIRES

Leerink Upgrades NeoGenomics to Outperform From Market Perform, Adjusts Price Target to $25 From $12

By

-- NeoGenomics (NEO) has an average rating of overweight and mean price target of $14.61, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles